File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Minimal change nephropathy and focal segmental glomerulosclerosis

TitleMinimal change nephropathy and focal segmental glomerulosclerosis
Authors
Issue Date2007
Citation
Seminars in Immunopathology, 2007, v. 29 n. 4, p. 415-426 How to Cite?
AbstractThe terms minimal change nephropathy and focal segmental glomerulosclerosis describe histopathological entities diagnosed by renal biopsy, typically in patients presenting with heavy proteinuria and its consequences including nephrotic syndrome. Numerous alterations in the immune response have been reported, but there is uncertainty about whether these play a causal role. In both conditions, there is evidence of injury to glomerular epithelial cells (podocytes), a cell type with limited potential for repair or replacement. The mechanisms of injury are poorly understood but may include immunologically mediated processes such as the effects of soluble mediators produced by lymphocytes. Empirical immunosuppressive therapy with corticosteroids, alkylating agents, and/or calcineurin antagonists is often effective, but the potential for toxicity of these drugs is enormous, and more specific forms of treatment are needed. The focus in recent years has been on the podocyte, and in particular the potential importance of mutations/polymorphisms in podocyte-specific genes as predisposing factors, mechanisms of podocyte injury including study of the role of podocytes as active participants in disease pathogenesis, indices of podocyte injury as markers of disease activity or possible diagnostic tools, and strategies for podocyte repair including the recognition that existing therapies may have effects (beneficial or adverse) on podocytes. Future improvements in the understanding of these diseases and in our ability to successfully treat them can be confidently expected as a result of rapid advances in the study of podocyte biology in health and disease. © 2007 Springer-Verlag.
Persistent Identifierhttp://hdl.handle.net/10722/195457
ISSN
2015 Impact Factor: 6.394
2015 SCImago Journal Rankings: 3.720
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMathieson, PW-
dc.date.accessioned2014-02-28T06:12:11Z-
dc.date.available2014-02-28T06:12:11Z-
dc.date.issued2007-
dc.identifier.citationSeminars in Immunopathology, 2007, v. 29 n. 4, p. 415-426-
dc.identifier.issn1863-2297-
dc.identifier.urihttp://hdl.handle.net/10722/195457-
dc.description.abstractThe terms minimal change nephropathy and focal segmental glomerulosclerosis describe histopathological entities diagnosed by renal biopsy, typically in patients presenting with heavy proteinuria and its consequences including nephrotic syndrome. Numerous alterations in the immune response have been reported, but there is uncertainty about whether these play a causal role. In both conditions, there is evidence of injury to glomerular epithelial cells (podocytes), a cell type with limited potential for repair or replacement. The mechanisms of injury are poorly understood but may include immunologically mediated processes such as the effects of soluble mediators produced by lymphocytes. Empirical immunosuppressive therapy with corticosteroids, alkylating agents, and/or calcineurin antagonists is often effective, but the potential for toxicity of these drugs is enormous, and more specific forms of treatment are needed. The focus in recent years has been on the podocyte, and in particular the potential importance of mutations/polymorphisms in podocyte-specific genes as predisposing factors, mechanisms of podocyte injury including study of the role of podocytes as active participants in disease pathogenesis, indices of podocyte injury as markers of disease activity or possible diagnostic tools, and strategies for podocyte repair including the recognition that existing therapies may have effects (beneficial or adverse) on podocytes. Future improvements in the understanding of these diseases and in our ability to successfully treat them can be confidently expected as a result of rapid advances in the study of podocyte biology in health and disease. © 2007 Springer-Verlag.-
dc.languageeng-
dc.relation.ispartofSeminars in Immunopathology-
dc.titleMinimal change nephropathy and focal segmental glomerulosclerosis-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s00281-007-0094-z-
dc.identifier.pmid17955243-
dc.identifier.scopuseid_2-s2.0-35948974274-
dc.identifier.volume29-
dc.identifier.issue4-
dc.identifier.spage415-
dc.identifier.epage426-
dc.identifier.isiWOS:000250787200008-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats